Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Phenylglycine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Explore the patented CN1293041C method for producing high-purity L-Phenylglycine. Discover cost-effective, low-waste manufacturing strategies for reliable pharmaceutical intermediate supply chains.
Novel synthesis of (R)-p-hydroxyphenylglycine via phenol condensation offers high yield and purity for beta-lactam antibiotic manufacturing, ensuring robust supply chain continuity.
Novel 2-step synthesis for D-p-hydroxyphenylglycine methyl ester hydrochloride. Reduces cost and waste for amoxicillin production. High purity and yield.
Novel recombinant E. coli route for D-HPG production offers cost reduction in API intermediate manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN104829478A details a high-purity crystallization process for pharmaceutical intermediates, offering significant supply chain stability and cost reduction advantages.
Patent CN115820584A reveals high-efficiency mutants for L-phenylglycine and L-2-aminobutyric acid synthesis, offering cost reduction and supply reliability.
Patent CN101003822A reveals immobilized enzyme hydrolysis for high-purity D-amino acids. Offers scalable production and cost reduction in pharmaceutical intermediates manufacturing.
Advanced synthesis route for high-purity antibiotic intermediates. Improves yield and stability via novel mother liquor recycling technology.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.
Patent CN110467537B reveals a streamlined 6-step synthesis for L-p-hydroxyphenylglycine, offering significant cost reduction and yield improvements for antibiotic manufacturers.
Patent CN102757367A details a cost-effective splitting process for DL-benzene ethyl sulfonic acid using L-HPG, offering high purity and supply chain stability for pharmaceutical intermediates.
Patent CN1091097C details a safe, high-purity route for N-substituted glycine esters, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN113896645A reveals a one-pot synthesis method for D-p-HPG. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102675135A details a mild, high-yield method for synthesizing alpha-amino acid esters using triethylamine catalysis, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN113896645B enables clean synthesis of D-p-HPG. Reduces waste and improves yield for reliable pharmaceutical intermediates supply chains.
Patent CN110330460B details a high-yield solid acid catalyzed route for p-hydroxyphenylhydantoin, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Reduce synthesis steps and costs for phenylglycine-based APIs with high-yield C-H functionalization. Scale to 100MT/yr with 99% purity and minimal waste.